HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

about

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

Item

http://www.wikidata.org/entity/Q49907625

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@en

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@nl

type

Item

label

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@en

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@nl

prefLabel

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@en

HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.

@nl

P1476

Human papilloma virus genotypi ...... lial neoplasia grade 2 or more

@en

P2093

Anna Gillio-Tos

http://www.w3.org/2001/XMLSchema#string

Annarosa Del Mistro

http://www.w3.org/2001/XMLSchema#string

Elena Burroni

http://www.w3.org/2001/XMLSchema#string

Jack Cuzick

http://www.w3.org/2001/XMLSchema#string

Laura De Marco

http://www.w3.org/2001/XMLSchema#string

Morena Trevisan

http://www.w3.org/2001/XMLSchema#string

New Technologies for Cervical CancerWorking Group

http://www.w3.org/2001/XMLSchema#string

Rachael Adcock

http://www.w3.org/2001/XMLSchema#string

Raffaella Rizzolo

http://www.w3.org/2001/XMLSchema#string

Salvatore Girlando

http://www.w3.org/2001/XMLSchema#string

P2860

A review of human carcinogens--Part B: biological agents

Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.

The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study.

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

P304

333-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.31326

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29453769

http://www.w3.org/2001/XMLSchema#string

P932

6099271

http://www.w3.org/2001/XMLSchema#string